<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-HZ3Z88FQ</identifier><date>2016</date><creator>Locatelli, Igor</creator><creator>Urbanc, Marina</creator><relation>documents/doc/H/URN_NBN_SI_doc-HZ3Z88FQ_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HZ3Z88FQ_001.txt</relation><format format_type="issue">5</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 325-332</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4223345</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HZ3Z88FQ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">antikonvulzivi</subject><subject language_type_id="slv">kapsaicin</subject><subject language_type_id="slv">nevropatska bolečina</subject><subject language_type_id="slv">opioidi</subject><title>The pharmacological treatment of neuropathic pain</title><title>Zdravila za zdravljenje nevropatske bolečine</title></Record>